Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4528 is 1,634.5 JPY — it has increased by 2.67% in the past 24 hours. Watch ONO PHARMACEUTICAL CO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange ONO PHARMACEUTICAL CO stocks are traded under the ticker 4528.
4528 stock has risen by 0.09% compared to the previous week, the month change is a −4.98% fall, over the last year ONO PHARMACEUTICAL CO has showed a −34.88% decrease.
We've gathered analysts' opinions on ONO PHARMACEUTICAL CO future price: according to them, 4528 price has a max estimate of 2,500.00 JPY and a min estimate of 1,400.00 JPY. Watch 4528 chart and read a more detailed ONO PHARMACEUTICAL CO stock forecast: see what analysts think of ONO PHARMACEUTICAL CO and suggest that you do with its stocks.
4528 reached its all-time high on Apr 12, 2016 with the price of 5,880.0 JPY, and its all-time low was 640.0 JPY and was reached on Nov 19, 2002. View more price dynamics on 4528 chart. See other stocks reaching their highest and lowest prices.
4528 stock is 1.54% volatile and has beta coefficient of 0.42. Track ONO PHARMACEUTICAL CO stock price on the chart and check out the list of the most volatile stocks — is ONO PHARMACEUTICAL CO there?
Today ONO PHARMACEUTICAL CO has the market capitalization of 766.33 B, it has decreased by −1.27% over the last week.
ONO PHARMACEUTICAL CO is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
4528 earnings for the last quarter are 35.87 JPY per share, whereas the estimation was 50.54 JPY resulting in a −29.02% surprise. The estimated earnings for the next quarter are 41.79 JPY per share. See more details about ONO PHARMACEUTICAL CO earnings.
ONO PHARMACEUTICAL CO revenue for the last quarter amounts to 122.66 B JPY, despite the estimated figure of 126.36 B JPY. In the next quarter, revenue is expected to reach 131.01 B JPY.
4528 net income for the last quarter is 16.86 B JPY, while the quarter before that showed 24.79 B JPY of net income which accounts for −32.00% change. Track more ONO PHARMACEUTICAL CO financial stats to get the full picture.
ONO PHARMACEUTICAL CO dividend yield was 3.26% in 2023, and payout ratio reached 30.01%. The year before the numbers were 2.53% and 30.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 30, 2024, the company has 3.85 K employees. See our rating of the largest employees — is ONO PHARMACEUTICAL CO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONO PHARMACEUTICAL CO EBITDA is 140.41 B JPY, and current EBITDA margin is 36.15%. See more stats in ONO PHARMACEUTICAL CO financial statements.
Like other stocks, 4528 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONO PHARMACEUTICAL CO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONO PHARMACEUTICAL CO technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONO PHARMACEUTICAL CO stock shows the sell signal. See more of ONO PHARMACEUTICAL CO technicals for a more comprehensive analysis. If you're still not sure, try looking for inspiration in our curated watchlists.